Anti-müllerian hormone - A predictor of ovarian reserve;Anti-müllerjev hormon - Napovednik ovarijske rezerve

Zdravniski Vestnik

Volumn 79, Issue 6, 2010, Pages 507-511

  Meden Vrtovec, Helena ^a   Osredkar, Joško ^a  

^a UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

Author keywords

Anti M llerian hormone; Ovarian reserve; Polycystic ovary syndrome; Premature ovarian failure

Indexed keywords

EID: 79951876423     PISSN: 13180347     EISSN: 15810224     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. Metcalf MG, Donald RA, Livesey JH. Pituitary-ovarian function in normal women during the menopausal transition. Clin Endocrinol 1981; 14: 245-55. (Pubitemid 11053525)
2. Metcalf MG, Donald RA. Fluctuating ovarian function in a perimenopausal women. N Z Med J 1979; 89: 45-7. (Pubitemid 9147594)
3. Klein NA, Illingworth PJ, Groome N P, McNeilly AS, Battaglia DE, Soules MR. Decreased inhibin B secretion is associated with the monotropic FSH rise in older, ovulatory women: a study of serum and follicular fluid levels of dimeric inhibin A and B in spontaneous menstrual cycles. J Clin Endocrinol Metab 1996; 81: 2742-5. (Pubitemid 26240306)
4. Csemiczky G, Harlin J, Fried G. Predictive power of clomiphene citrate challenge test for failure of in vitro fertilization treatment. Acta Obstet Gynecol Scand 2002; 81: 954-61. (Pubitemid 35176988)
5. Bukman A, Heineman MJ. Ovarian reserve testing and the use of prognostic models in patients with subfertility. Hum Reprod Update 2001; 7: 581-90. (Pubitemid 33069617)
6. Erdem M, Erdem A, Biberoglu K, Arslan M. Age-related changes in ovarian volume, antral follicle counts and basal follicle stimulating hormone levels: comparison between fertile and infertile women. Gynecol Endocrinol 2003; 17: 199-205. (Pubitemid 36760720)
7. Behringer RR. The in vivo roles of Müllerian-inhibiting substance. Curr Top Dev Biol 1994; 29: 171-87.
8. Weenen C, Laven JS, Von Bergh AR, Cranfield M, Groome NP, Visser JA, et al. Anti-Müllerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment. Mol Hum Reprod 2004; 10: 77-83. (Pubitemid 38196508)
9. Visser JA, de Jong FH, Laven JS, Themmen AP. Anti-Müllerian hormone: a new marker for ovarian function. Reproduction 2006; 131: 1-9. (Pubitemid 43230697)
10. Mulders AG, Laven JS, Eijkemans MJ, de Jong FH, Themmen AP, Fauser BC. Changes in anti-Müllerian hormone serum concentrations over time suggest delayed ovarian ageing in normogonadotrophic anovulatory infertility. Hum Reprod 2004; 19: 2036-42. (Pubitemid 39236470)
11. Fanchin R, Schonäuer LM, Righini C, Guibourdenche J, Frydman R, Taieb J. Serum anti-Müllerian hormone is more strongly related to ovarian follicular status than serum inhibin B, estradiol, FSH and LH on day 3. Hum Reprod 2003; 18: 323-7. (Pubitemid 36236265)
12. Fanchin R, Taieb J, Lozano DH, Ducot B, Frydman R, Bouyer J. High reproducibility of serum anti-Mullerian hormone measurements suggests a multi-staged follicular secretion and strengthens its role in the assessment of ovarian follicular status. Hum Reprod 2005; 20: 923-7. (Pubitemid 40667836)
13. La Marca A, Giulini S, Orvieto R, De Leo V, Volpe A. Anti-Müllerian hormone concentrations in maternal serum during pregnancy. Hum Reprod 2005; 20: 1569-72. (Pubitemid 40852249)
14. La Marca A, Malmusi S, Giulini S, Tamaro LF, Orvieto R, Levratti P, et al. Anti-Müllerian hormone plasma levels in spontaneous menstrual cycle and during treatment with FSH to induce ovulation. Hum Reprod 2004; 19: 2738-41. (Pubitemid 40028941)
15. Fanchin R, Schonäuer LM, Righini C, Frydman N, Frydman R, Taieb J. Serum anti-Müllerian hormone dynamics during controlled ovarian hyperstimulation. Hum Reprod 2003; 18: 328-32. (Pubitemid 36236266)
16. Baarends WM, Uilenbroek JT, Kramer P, Hoogerbrugge JW, van Leeuwen EC, Themmen AP, et al. Anti-Müllerian hormone and anti-Müllerian hormone type II receptor messenger ribonucleic acid expression in rat ovaries during postnatal development, the estrous cycle, and gonadotropin-induced follicle growth. Endocrinology 1995; 136: 4951-62.
17. Ebner T, Sommergruber M, Moser M, Shebl O, Schreier-Lechner E, Tews G. Basal level of anti - Müllerian hormone is associated with oocyte quality in stimulated cycles. Hum Reprod 2006; 21: 2022-6. (Pubitemid 44288076)
18. Fénichel P, Rey R, Poggioli S, Donzeau M, Chevallier D, Pointis G. Anti-Müllerian hormone as a seminal marker for spermatogenesis in non-obstructive azoospermia. Hum Reprod 1999; 14: 2020-4. (Pubitemid 29381239)
19. Tüttelmann F, Dykstra N, Themmen A P, Visser JA, Nieschlag E, Simoni M. Anti-Müllerian hormone in men with normal and reduced sperm concentration and men with maldescended testes. Fertil Steril 2009; 91: 1812-9.
20. Rey RA, Belville C, Nihoul-Fékété C, Michel-Calemard L, Forest MG, Lahlou N, et al. Evaluation of gonadal function in 107 intersex patients by means of serum antimüllerian hormone measurement. J Clin Endocrinol Metab 1999; 84: 627-31. (Pubitemid 29075696)
21. Greenfield DM, Walters SJ, Ross RJM, Coleman RE, Hancock BV, Snowden JA, et al. Inhibin B and AMH are not predictors of serum testosterone in young men after cancer. Endocrine 2009; 19: P286.
22. Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004; 19: 41-7.
23. Pigny P, Merlen E, Robert Y, Cortet-Rudelli C, Decanter C, Jonard S, et al. Elevated serum level of anti-Müllerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest. J Clin Endocrinol Metab 2003; 88: 5957-62. (Pubitemid 38033078)
24. Laven JS, Mulders AG, Visser JA, Themmen AP, De Jong FH, Fauser BC. Anti-Müllerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age. J Clin Endocrinol Metab 2004; 89: 318-23. (Pubitemid 38183899)
25. Franks S, Gilling-Smith C, Watson H, Willis D. Insulin action in the normal and polycystic ovary. Endocrinol Metab Clin North Am 1999; 28: 361-78. (Pubitemid 29242718)
26. Fleming R, Harborne L, MacLaughlin DT, Ling D, Norman J, Sattar N, et al. Metformin reduces serum mullerian-inhibiting substance levels in women with polycystic ovary syndrome after protracted treatment. Fertil Steril 2005; 83: 130-6. (Pubitemid 40094791)
27. Webber LJ, Stubbs S, Stark J, Trew GH, Margara R, Hardy K, et al. Formation and early development of follicles in the polycystic ovary. Lancet 2003; 362: 1017-21. (Pubitemid 37186878)
28. Piltonen T, Morin-Papunen L, Koivunen R, Perheentupa A, Ruokonen A, Tapanainen JS. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome. Hum Reprod 2005; 20: 1820-6. (Pubitemid 40932362)
29. Wachs DS, Coffler MS, Malcom PJ, Chang RJ. Serum anti-Müllerian hormone concentrations are not altered by acute administration of follicle stimulating hormone in polycystic ovary syndrome and normal women. J Clin Endocrinol Metab 2007; 92: 1871-4. (Pubitemid 46997202)
30. Meden-Vrtovec H, Levičnik A, Ihan A, Vizjak A. Avtoimunski vidiki prezgodnje menopavze. Zdrav Vestn 2009; 78 Suppl 1: 151-7.